References
- Simons FE. H1-antihistamines in children. Clin Allergy Immunol 2002;17:437–64
- Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:478–518
- Spaeth J, Klimek L, Mosges R. Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 1996;51:893–906
- Wilken JA, Berkowitz R, Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol 2002;89:372–80
- Vuurman EF, Van Veggel LM, Uiterwijk MM, Leutner D, O’Hanlon JF. Seasonal allergic rhinitis and antihistamine effects on children’s learning. Ann Allergy 1993;71:121–6
- American Academy of Allergy, Asthma & Immunology. The allergy report, vol. 1: overview of allergic diseases. Milwaukee (WI): Author; 2000
- Skoner DP. Complications of allergic rhinitis. J Allergy Clin Immunol 2000;105:S605–9
- Simons FER. Allergic rhinobronchitis: the asthma–allergic rhinitis link. J Allergy Clin Immunol 1999;104:534–40
- DuBuske LM. The link between allergy and asthma. Allergy Asthma Proc 1999;20:341–5
- Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997;133:1003–8
- Greaves MW. Chronic urticaria in childhood. Allergy 2000;55:309–20
- O’Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997;136:197–201
- Weston WL, Badgett JT. Urticaria. Pediatr Rev 1998;19:240–4
- Schenkel EJ. Paediatric issues relating to the pharmacotherapy of allergic rhinitis. Exp Opin Pharmacother 2000;1:1–18
- Greaves MW. Chronic urticaria. N Engl J Med 1995;332:1767–72
- Simons FE, Fraser TG, Reggin JD, Roberts JR, Simons KJ. Adverse central nervous system effects of older antihistamines in children. Pediatr Allergy Immunol 1996;7:22–7
- Yap YG, Camm AJ. Arrhythmogenic mechanisms of non-sedating antihistamines. Clin Exp Allergy 1999;29(Suppl 3):174–81
- Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena Jr LR. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788–90
- Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986;292:660
- Meltzer E, Prenner B, Nayak A, Desloratadine Study Group. Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: assessment during the spring and fall allergy seasons. Clin Drug Invest 2001;21: 25–32
- Simons FER, Prenner BM, Finn Jr A. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol 2003;111:617–22
- Monroe E, Finn A, Patel P, Guerrero R, Ratner P, Bernstein D. Efficacy and safety of desloratadine 5mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2003;48:535–41
- Banfield C, Gupta S, Affrime M, Batra V. Pharmacokinetic equivalence of pediatric dosages of desloratadine syrup in children and standard 5-mg desloratadine tablets in adults. J Allergy Clin Immunol 2002;109:S103 [abstract]
- Banfield C, Herron J, Keung A, Padhi D, Affrime M. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole. Clin Pharmacokinet 2002;41(Suppl 1):37–44